MedPath

Pelage Pharmaceuticals, Inc.

Pelage Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Employees
1
Market Cap
-
Website
https://pelagepharma.com

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Phase 2
Active, not recruiting
Conditions
Androgenetic Alopecia
Interventions
Drug: PP405 Topical Vehicle Gel
First Posted Date
2024-05-01
Last Posted Date
2025-07-09
Lead Sponsor
Pelage Pharmaceuticals, Inc.
Target Recruit Count
78
Registration Number
NCT06393452
Locations
🇺🇸

California Dermatology & Clinical Research Institute, Encinitas, California, United States

🇺🇸

Clinical Trials Research Institute, Thousand Oaks, California, United States

🇺🇸

Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States

and more 5 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.